The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients
Open accessAbstract
We assessed the clinical utility of [11C]flumazenil-PET (FMZ-PET) prospectively in 100 epileptic patients undergoing a pre-surgical evaluation, and defined the specific contribution of this neuro-imaging technique with respect to those of MRI and [18F]fluorodeoxyglucose-PET (FDG-PET). All patients benefited from a long term video-EEG monitoring, whereas an intracranial EEG investigation was performed in 40 cases. Most of our patients (73%) demonstrated a FMZ-PET abnormality; this hit rate was significantly higher in temporal lobe epilepsy (94%) than in other types of epilepsy (50%) (P < 0.001). Most FMZ-PET findings coexisted with a MRI abnormality (81%), including hippocampal atrophy (35%) and focal hypometabolism on FDG-PET (89%). The area of decreased FMZ binding was often smaller than that of glucose hypometabolism (48%) or larger than that of the MRI abnormality (28%). FMZ-PET did not prove superior to FDG-PET in assessing the extent of the ictal onset zone, as defined by intracranial EEG recordings. However, it provided useful data which were complementary to those of MRI and FDG-PET in three situations: (i) in temporal lobe epilepsy associated with MRI signs of hippocampal sclerosis, FMZ-PET abnormalities delineated the site of seizure onset precisely, whenever they were coextensive with FDG-PET abnormalities; (ii) in bi-temporal epilepsy, FMZ-PET helped to confirm the bilateral origin of seizures by showing a specific pattern of decreased FMZ binding in both temporal lobes in 33% of cases; (iii) in patients with a unilateral cryptogenic frontal lobe epilepsy, FMZ-PET provided further evidence of the side and site of seizure onset in 55% of cases. Thus, FMZ-PET deserves to be included in the pre-surgical evaluation of these specific categories of epileptic patients, representing approximately half of the population considered for epilepsy surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI
Savic, I., Roland, P., Sedvall, G., Persson, A., Pauli, S., & Widen, L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92468-3 · Cited by 367
Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal
Arruda, F., Cendes, F., Andermann, F., Dubeau, F., Villemure, J. G., Jones‐Gotman, M., Poulin, N., Arnold, D. L., & Olivier, A. (1996) · Annals of Neurology · doi:10.1002/ana.410400314 · Cited by 234
In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy
Henry, T. R., Frey, K. A., Sackellares, J. C., Gilman, S., Koeppe, R. A., Brunberg, J. A., Ross, D. A., Berent, S., Young, A. B., & Kuhl, D. E. (1993) · Neurology · doi:10.1212/wnl.43.10.1998 · Cited by 190
Shin, C., Pedersen, H., & McNamara, J. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-10-02696.1985 · Cited by 163
Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.
Savic, I., Ingvar, M., & Stone-Elander, S. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.615 · Cited by 159
Repeated seizures induce long-term increase in hippocampal benzodiazepine receptors.
McNamara, J. O., Peper, A., & Patrone, V. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.3029 · Cited by 148
Semah, F., Baulac, M., Hasboun, D., et al. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00485.x · Cited by 126
Valdés, F., Dasheiff, R. M., Birmingham, F., Crutcher, K. A., & McNamara, J. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.1.193 · Cited by 112
Cerebral benzodiazepine receptors in hippocampal sclerosis
Koepp, M. J., Richardson, M. P., Brooks, D. J., Poline, J.-B., Paesschen, W. V., Friston, K. J., & Duncan, J. S. (1996) · Brain · doi:10.1093/brain/119.5.1677 · Cited by 111
Debets, R. M. C., Sadzot, B., van Isselt, J. W., Brekelmans, G. J. F., Meiners, L. C., van Huffelen, A. C., Franck, G., & Veelen, C. W. M. V. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.2.141 · Cited by 89
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Kanner, A. M., Schachter, S. C., Barry, J. J., Hersdorffer, D. C., Mula, M., Trimble, M., Hermann, B., Ettinger, A. E., Dunn, D., Caplan, R., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.01.007 · Cited by 295
Self-citationHippocampal sclerosis—Origins and imaging
Malmgren, K., & Thom, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03610.x · Cited by 273
Surgery for malformations of cortical development causing epilepsy
Sisodiya, S. M. (2000) · Brain · doi:10.1093/brain/123.6.1075 · Cited by 266
PET and SPECT in epilepsy: a critical review.
la Fougère, C., Rominger, A., Förster, S., Geisler, J., & Bartenstein, P. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.025 · Cited by 224
Metadata
- Authors
- Ryvlin, P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-11-01
- Volume
- 121
- Issue
- 11
- Pages
- 2067-2081
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2057452693
- Cited by
- 252
- References
- 15
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. https://app.cochat.ai/papers/10.1093/brain/121.11.2067
- The paper
- Ryvlin, P. (1998). Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain. https://doi.org/10.1093/brain/121.11.2067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.